Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Frequently asked questions
What sector does Envoy Medical Inc. (COCH) operate in?
Envoy Medical Inc. belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Envoy Medical Inc. (COCH) current stock price?
As of the latest data, Envoy Medical Inc. stock price is $0.75, with a previous close of $0.74. Envoy Medical Inc. gained $0.02 in the last trading session, representing a 2.04% increase.
What is Envoy Medical Inc. (COCH) current market capitalization?
Envoy Medical Inc. market cap is approximately 57.90 million.
What is Envoy Medical Inc. (COCH) Earnings Per Share (EPS)?
The trailing EPS is -$0.76, and the forward EPS is -$0.23.
What is Envoy Medical Inc. (COCH) EBITDA?
Envoy Medical Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -5.16 million.
Does Envoy Medical Inc. (COCH) pay dividends?
No. Envoy Medical Inc. does not pay a dividend.
How did Envoy Medical Inc. (COCH) perform in its most recent earnings report?
In the last report (June 30, 2026), Envoy Medical Inc. posted an EPS surprise of 22.22% and a revenue surprise of -36.25%.
What is Envoy Medical Inc. (COCH) beta (volatility) score?
Envoy Medical Inc. has a beta of 1.889, suggesting it is more volatile than the market.
